In regard to "the return of the snake oil salesman" (IJROBP 2003;55:561-562, and 56:1507-1508) [8]

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 5, 2004, Pages 1644-

  Dearnaley, David P ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; HEAD AND NECK CANCER; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LETTER; PELVIS CANCER; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION;

ADVERTISING; CLINICAL TRIALS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MARKETING OF HEALTH SERVICES; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL;

EID: 1842424192     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.11.014     Document Type: Letter

References (3)

1. Dearnaley D.P., Khoo V.S., Norman A., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy techniques in prostate cancer." A randomised trial. Lancet. 353:1999;267-272.
2. Dearnaley D.P., Aird E.G., Bidmead A.M., et al. on behalf of all the RT01 Trial participants. High dose conformal radiotherapy (RT) in localised prostate cancer The MRC RT01 randomised trial. J Clin Oncol. 21:2002;193a.
3. NHS NICE Guidance on Cancer Services. Improving Outcomes in Urological Cancers - The Manual. 2002;. http://www.nice.org.uk/cat.asp?c=36469